To obtain additional information as to the role of cancer cell-derived GM-CSF in the progression of the 4T1 breast cancer, we generated GM-CSF-deficient 4T1 cells by using the CRISPR-Cas9 system. The gene discussed is CSF2; the disease is breast carcinoma.